Scholl, S, Popovic, M, de la Rochefordiere, A, Girard, E, Dureau, S, Mandic, A, Koprivsek, K, Samet, N, Craina, M, Margan, M, Samuels, S, Zijlmans, H, Kenter, G, Hillemanns, P, Dema, S, Dema, A, Malenkovic, G, Djuran, B, Floquet, A, Garbay, D, Guyon, F, Colombo, P E, Fabbro, M, Kerr, C, Ngo, C, Lecuru, F, del Campo, E R, Coutant, C, Marchal, F, Mesgouez-Nebout, N, Fourchotte, V, Feron, J G, Morice, P, Deutsch, E, Wimberger, P, Classe, J-M, Gleeson, N, von der Leyen, H, Minsat, M, Dubot, C, Gestraud, P, Kereszt, A, Nagy, I, Balint, B, Berns, E, Jordanova, E, de Saint-Jorre, N, Savignoni, A, Servant, N, Hupe, P, de Koning, L, Fumoleau, P, Rouzier, R & Kamal, M 2020, ' Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer : Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)) ', EBioMedicine, vol. 57, 102875 . https://doi.org/10.1016/j.ebiom.2020.102875